Toth Financial Advisory Corp Buys 3,246 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Toth Financial Advisory Corp increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 10.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,433 shares of the financial services provider’s stock after acquiring an additional 3,246 shares during the quarter. Toth Financial Advisory Corp’s holdings in iShares Biotechnology ETF were worth $4,862,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. Future Financial Wealth Managment LLC acquired a new stake in iShares Biotechnology ETF during the first quarter worth approximately $27,000. Pacifica Partners Inc. increased its stake in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 130 shares in the last quarter. Crewe Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 42.9% during the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 78 shares during the period. Northwest Financial Advisors bought a new position in iShares Biotechnology ETF during the fourth quarter worth $42,000. Finally, Values First Advisors Inc. bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at $43,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB stock traded down $0.65 on Friday, reaching $137.26. 1,282,683 shares of the company were exchanged, compared to its average volume of 1,131,735. The company has a 50-day moving average of $134.42 and a 200-day moving average of $134.82. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.